These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 11079794

  • 1. Current trends in bladder cancer treatment.
    Lamm DL, Allaway M.
    Ann Chir Gynaecol; 2000; 89(3):234-41. PubMed ID: 11079794
    [No Abstract] [Full Text] [Related]

  • 2. Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer.
    Stein JP, Penson DF, Lee C, Cai J, Miranda G, Skinner DG.
    J Urol; 2009 May; 181(5):2052-8; discussion 2058-9. PubMed ID: 19286213
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M.
    Ann Acad Med Stetin; 2000 May; 46():217-29. PubMed ID: 11712306
    [Abstract] [Full Text] [Related]

  • 6. Proton beam therapy for invasive bladder cancer: a prospective study of bladder-preserving therapy with combined radiotherapy and intra-arterial chemotherapy.
    Hata M, Miyanaga N, Tokuuye K, Saida Y, Ohara K, Sugahara S, Kagei K, Igaki H, Hashimoto T, Hattori K, Shimazui T, Akaza H, Akine Y.
    Int J Radiat Oncol Biol Phys; 2006 Apr 01; 64(5):1371-9. PubMed ID: 16580495
    [Abstract] [Full Text] [Related]

  • 7. Bladder-sparing therapy for muscle-infiltrating bladder cancer.
    Pansadoro V, Emiliozzi P.
    Nat Clin Pract Urol; 2008 Jul 01; 5(7):368-75. PubMed ID: 18560383
    [Abstract] [Full Text] [Related]

  • 8. Patterns of recurrence and outcomes following induction bacillus Calmette-Guerin for high risk Ta, T1 bladder cancer.
    Lerner SP, Tangen CM, Sucharew H, Wood D, Crawford ED.
    J Urol; 2007 May 01; 177(5):1727-31. PubMed ID: 17437798
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only.
    de Vries RR, Nieuwenhuijzen JA, Meinhardt W, Bais EM, Horenblas S.
    Eur J Surg Oncol; 2009 Apr 01; 35(4):352-5. PubMed ID: 18722076
    [Abstract] [Full Text] [Related]

  • 11. Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer.
    Lehmann J, Franzaring L, Thüroff J, Wellek S, Stöckle M.
    BJU Int; 2006 Jan 01; 97(1):42-7. PubMed ID: 16336326
    [Abstract] [Full Text] [Related]

  • 12. Oncological and functional outcome of radical cystectomy in patients with bladder cancer and obstructive uropathy.
    Gupta NP, Kolla SB, Seth A, Hemal AK, Dogra PN, Kumar R.
    J Urol; 2007 Oct 01; 178(4 Pt 1):1206-11; discussion 1211. PubMed ID: 17698145
    [Abstract] [Full Text] [Related]

  • 13. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L, Bladou F, Bardou VJ, Gravis G, Tallet A, Alzieu C, Serment G, Salem N.
    Urology; 2004 Sep 01; 64(3):488-93. PubMed ID: 15351577
    [Abstract] [Full Text] [Related]

  • 14. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
    Solsona E, Iborra I, Ricos JV, Monros JL, Rubio J, Almenar S.
    J Urol; 2002 May 01; 167(5):2007-11. PubMed ID: 11956428
    [Abstract] [Full Text] [Related]

  • 15. [Cyclooxygenase-2-expression in bladder cancer: tumor-biological and clinical implications].
    Wülfing C, Eltze E, Von Struensee D, Wülfing P, Bode ME, Bettendorf O, Piechota H, Hertle L.
    Aktuelle Urol; 2004 Aug 01; 35(4):331-8. PubMed ID: 15459875
    [Abstract] [Full Text] [Related]

  • 16. The risk factor for urethral recurrence after radical cystectomy in patients with transitional cell carcinoma of the bladder.
    Cho KS, Seo JW, Park SJ, Lee YH, Choi YD, Cho NH, Yang SC, Hong SJ.
    Urol Int; 2009 Aug 01; 82(3):306-11. PubMed ID: 19440019
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Long-term results of intravesical N-CWS therapy for preventing bladder cancer recurrence after operation.
    Chen S, Lin Z, Ye C, Xu E.
    Chin Med J (Engl); 1996 Nov 01; 109(11):890-1. PubMed ID: 9275378
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.